AIC
HBIO icon

Atlantic Investment Company’s Harvard Bioscience HBIO Stock Holding History

Atlantic Investment Company’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,324
Closed -$62K – 57
2013
Q4 		$62K Sell
1,324
-16,910
-93% -$739K 0.05% 55
2013
Q3 		$727K Buy
+18,234
New +$717K 0.47% 19

Other funds holding HBIO

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Atlantic Investment Company's HBIO Position: Q1 2014 in Review

Atlantic Investment Company sold out of Harvard Bioscience (HBIO) in Q1 2014, closing a stake of 1,324 shares — an estimated $62K sold.

Atlantic Investment Company first reported a position in HBIO in Q3 2013 and held it in 2 quarters. The position peaked at $727K in Q3 2013. 74 funds tracked by Wall St. Rank hold HBIO as of Q1 2014.

  • Atlantic Investment Company reported no remaining Harvard Bioscience position as of Q1 2014 after selling out during the quarter.
  • Atlantic Investment Company sold 1,324 Harvard Bioscience shares in Q1 2014, an estimated $62K.
  • Atlantic Investment Company first reported a position in Harvard Bioscience in Q3 2013 and held it in 2 quarters.
  • Atlantic Investment Company's Harvard Bioscience position peaked at $727K in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2014.

Based on Atlantic Investment Company's 13F filing for Q1 2014, filed 13 May 2014.